Search Results: Displaying all items (9)

First Author Title Journal Publication Date
Faurholt-Jepsen D. Diabetes is associated with lower tuberculosis antigen-specific interferon gamma release in Tanzanian tuberculosis patients and non-tuberculosis controls. Scandinavian journal of infectious diseases 2014
Hara M. [A case of tuberculous peritonitis in a hemodialysis patient revealed by severe diarrhea and stomachache]. Nihon Jinzo Gakkai shi 2013
Redelman-Sidi G. Interferon Gamma Release Assays in the Diagnosis of Latent Tuberculosis Infection Among Immunocompromised Adults. American journal of respiratory and critical care medicine 2012
Pérez-Guzmán C. When TB associates with diabetes. Expert review of anti-infective therapy 2012
Jung JY. Questionable role of interferon-γ assays for smear-negative pulmonary TB in immunocompromised patients. The Journal of infection 2012
Ito I. [Analysis of usefulness of a whole blood interferon gamma assay (QuantiFERON TB-2G for diagnosing active tuberculosis in immunocompromised patients]. Kekkaku : [Tuberculosis] 2011
Walsh MC. The sensitivity of interferon-gamma release assays is not compromised in tuberculosis patients with diabetes. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2011
Lane C. Accelerated Decline of GFR in Diabetic Nephropathy Predicted by Interferon Release Assay to Tuberculosis Antigens. Nephron. Clinical practice 2010
Kobashi Y. Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients. The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2007